![](https://www.medicaldevice-network.com/wp-content/uploads/sites/23/2024/06/shutterstock_2435925961.png)
FDA expands Fractyl endoscopy trial to include untreated diabetes patients
The US Food and Drug Administration (FDA) has given the green light for metabolic therapeutics company, Fractyl Health, to expand the REVITALIZE-1 clinical study for its endoscopic device to include patients with type 2 diabetes. The REVITALIZE-1 ( …